NASDAQ:ALZN   Alzamend Neuro, Inc.
$ALZN (Alzamed Neuro Inc) is a preclinical stage biopharmaceutical company focused on developing products for the treatment of neurodegenerative diseases and psychiatric disorders.
It seems to be creating a demand zone with bullish RSI divergence and good spikes at volume.
Invalidation with a daily close under 4,42$.
Daily chart.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。